Insider Selling: Intuitive Surgical (NASDAQ:ISRG) Director Sells $510,370.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Craig Barratt sold 1,150 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total transaction of $510,370.00. Following the sale, the director owned 1,150 shares in the company, valued at $510,370. This represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded down $0.66 during mid-day trading on Monday, hitting $451.63. The company’s stock had a trading volume of 2,916,696 shares, compared to its average volume of 2,433,892. The firm’s 50 day moving average is $395.50 and its 200 day moving average is $408.83. The company has a market cap of $156.55 billion, a PE ratio of 54.61, a price-to-earnings-growth ratio of 3.12 and a beta of 1.46. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. During the same period last year, the company posted $2.40 EPS. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. As a group, analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts and market commentators continue to view Intuitive Surgical as a strong growth company, citing durable demand for robotic-assisted surgery and potential for the stock to outperform the broader market. Intuitive Surgical Is an Incredible Growth Stock: 3 Reasons Why
• Positive Sentiment: Higher earnings estimates are providing a near-term bullish catalyst. The revisions suggest analysts are becoming more optimistic about ISRG’s financial outlook, potentially supporting further gains. Earnings Estimates Moving Higher for Intuitive Surgical
• Neutral Sentiment: ISRG is receiving elevated investor attention across financial websites, but the “trending stock” coverage is primarily informational rather than a new business or earnings announcement. Intuitive Surgical Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Commentary is also addressing whether Intuitive Surgical’s premium valuation is justified. This may keep investors selective even as the company’s long-term growth story remains intact. If Intuitive Surgical Stock Looks Expensive, You Need To Read This
• Negative Sentiment: Director Gary Guthart sold 20,095 shares for approximately $9.1 million, reducing his direct ownership by 1.64%. Because the sale was made under a pre-arranged Rule 10b5-1 plan, it may not reflect a change in the company’s outlook, but insider selling can still weigh on sentiment. SEC Insider Transaction Filing

Institutional Trading of Intuitive Surgical

Several hedge funds and other institutional investors have recently bought and sold shares of ISRG. 3Chopt Investment Partners LLC boosted its holdings in Intuitive Surgical by 5.2% in the first quarter. 3Chopt Investment Partners LLC now owns 462 shares of the medical equipment provider’s stock valued at $213,000 after acquiring an additional 23 shares during the last quarter. Beaumont Financial Advisors LLC raised its holdings in Intuitive Surgical by 3.8% during the 3rd quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock worth $255,000 after purchasing an additional 23 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co raised its holdings in Intuitive Surgical by 1.0% during the 1st quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock worth $1,172,000 after purchasing an additional 25 shares during the last quarter. Blue Fin Capital Inc. raised its holdings in Intuitive Surgical by 0.5% during the 1st quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after purchasing an additional 25 shares during the last quarter. Finally, Red Spruce Capital LLC lifted its position in Intuitive Surgical by 4.1% during the 2nd quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock valued at $255,000 after purchasing an additional 25 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on ISRG shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. Robert W. Baird boosted their price target on shares of Intuitive Surgical from $513.00 to $550.00 and gave the company an “outperform” rating in a report on Wednesday, October 21st. Royal Bank Of Canada dropped their price target on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 21st. Leerink Partners set a $503.00 price target on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 21st. Finally, Mizuho cut their price objective on Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating for the company in a report on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $493.54.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.